Titre : Perception visuelle

Perception visuelle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Desogestrel

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment évaluer la perception visuelle ?

Des tests de vision, comme l'optométrie, évaluent la perception visuelle.
Évaluation de la vision Tests de vision
#2

Quels examens pour troubles de la perception ?

L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception.
Imagerie par résonance magnétique Électrorétinogramme
#3

Quels signes indiquent un problème visuel ?

Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème.
Troubles de la vision Illusions visuelles
#4

Quand consulter un spécialiste de la vue ?

Consultez un ophtalmologiste si vous ressentez des changements soudains de vision.
Ophtalmologie Changements de vision
#5

Quelles sont les causes de troubles visuels ?

Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques.
Maladies oculaires Traumatismes oculaires

Symptômes 5

#1

Quels symptômes de troubles de la perception ?

Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur.
Vision floue Difficultés de profondeur
#2

Comment reconnaître une illusion visuelle ?

Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs.
Illusions visuelles Perception visuelle
#3

Qu'est-ce que l'agnosie visuelle ?

L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte.
Agnosie Troubles de la perception
#4

Quels signes d'une fatigue visuelle ?

Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé.
Fatigue visuelle Maux de tête
#5

Comment se manifeste la synesthésie visuelle ?

La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons.
Synesthésie Perception sensorielle

Prévention 5

#1

Comment prévenir les troubles de la perception ?

Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers.
Prévention des troubles visuels Lunettes de soleil
#2

Quel rôle joue l'alimentation sur la vision ?

Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision.
Nutrition Vitamines
#3

Comment réduire la fatigue visuelle ?

Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle.
Fatigue visuelle Utilisation d'écrans
#4

Pourquoi éviter le tabac pour la vision ?

Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire.
Tabagisme Dégénérescence maculaire
#5

L'exercice physique aide-t-il la vision ?

Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire.
Exercice physique Santé oculaire

Traitements 5

#1

Quels traitements pour troubles de la perception ?

Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie.
Thérapie visuelle Chirurgie oculaire
#2

Comment la thérapie visuelle aide-t-elle ?

La thérapie visuelle améliore la coordination œil-main et la perception visuelle.
Thérapie visuelle Coordination œil-main
#3

Les lunettes corrigent-elles la perception ?

Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle.
Lunettes Erreurs de réfraction
#4

Quand envisager une chirurgie oculaire ?

La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome.
Chirurgie de la cataracte Glaucome
#5

Quels médicaments pour troubles visuels ?

Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires.
Médicaments ophtalmiques Glaucome

Complications 5

#1

Quelles complications des troubles visuels ?

Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels.
Perte de vision Troubles émotionnels
#2

Comment les troubles visuels affectent-ils la vie quotidienne ?

Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité.
Activités quotidiennes Mobilité
#3

Quels risques de dépression avec troubles visuels ?

Les troubles visuels augmentent le risque de dépression en raison de l'isolement social.
Dépression Isolement social
#4

Les troubles de la perception peuvent-ils s'aggraver ?

Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps.
Aggravation des troubles Traitement
#5

Quelles sont les conséquences d'une agnosie visuelle ?

L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales.
Agnosie Interactions sociales

Facteurs de risque 5

#1

Quels facteurs de risque pour troubles visuels ?

Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques.
Âge Antécédents familiaux
#2

Le diabète augmente-t-il les risques visuels ?

Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique.
Diabète Rétinopathie diabétique
#3

Comment l'hypertension affecte-t-elle la vision ?

L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels.
Hypertension Vaisseaux sanguins
#4

Le stress influence-t-il la perception visuelle ?

Oui, le stress peut affecter la concentration et la clarté de la perception visuelle.
Stress Concentration
#5

Les antécédents de traumatismes oculaires sont-ils un risque ?

Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle.
Traumatismes oculaires Risques visuels
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Perception visuelle : Questions médicales les plus fréquentes", "headline": "Perception visuelle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Perception visuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-29", "dateModified": "2025-04-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Perception visuelle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Perception", "url": "https://questionsmedicales.fr/mesh/D010465", "about": { "@type": "MedicalCondition", "name": "Perception", "code": { "@type": "MedicalCode", "code": "D010465", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Clignement attentionnel", "alternateName": "Attentional Blink", "url": "https://questionsmedicales.fr/mesh/D054518", "about": { "@type": "MedicalCondition", "name": "Clignement attentionnel", "code": { "@type": "MedicalCode", "code": "D054518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.145" } } }, { "@type": "MedicalWebPage", "name": "Perception des couleurs", "alternateName": "Color Perception", "url": "https://questionsmedicales.fr/mesh/D003118", "about": { "@type": "MedicalCondition", "name": "Perception des couleurs", "code": { "@type": "MedicalCode", "code": "D003118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.217" } } }, { "@type": "MedicalWebPage", "name": "Perception du mouvement", "alternateName": "Motion Perception", "url": "https://questionsmedicales.fr/mesh/D009039", "about": { "@type": "MedicalCondition", "name": "Perception du mouvement", "code": { "@type": "MedicalCode", "code": "D009039", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.567" } } }, { "@type": "MedicalWebPage", "name": "Reconnaissance visuelle des formes", "alternateName": "Pattern Recognition, Visual", "url": "https://questionsmedicales.fr/mesh/D010364", "about": { "@type": "MedicalCondition", "name": "Reconnaissance visuelle des formes", "code": { "@type": "MedicalCode", "code": "D010364", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.622" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Reconnaissance faciale", "alternateName": "Facial Recognition", "url": "https://questionsmedicales.fr/mesh/D000066499", "about": { "@type": "MedicalCondition", "name": "Reconnaissance faciale", "code": { "@type": "MedicalCode", "code": "D000066499", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.622.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Clôture perceptive", "alternateName": "Perceptual Closure", "url": "https://questionsmedicales.fr/mesh/D010466", "about": { "@type": "MedicalCondition", "name": "Clôture perceptive", "code": { "@type": "MedicalCode", "code": "D010466", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.677" } } }, { "@type": "MedicalWebPage", "name": "Vision binoculaire", "alternateName": "Vision, Binocular", "url": "https://questionsmedicales.fr/mesh/D015348", "about": { "@type": "MedicalCondition", "name": "Vision binoculaire", "code": { "@type": "MedicalCode", "code": "D015348", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.885" } } }, { "@type": "MedicalWebPage", "name": "Vision monoculaire", "alternateName": "Vision, Monocular", "url": "https://questionsmedicales.fr/mesh/D015349", "about": { "@type": "MedicalCondition", "name": "Vision monoculaire", "code": { "@type": "MedicalCode", "code": "D015349", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.593.932.893" } } } ], "about": { "@type": "MedicalCondition", "name": "Perception visuelle", "alternateName": "Visual Perception", "code": { "@type": "MedicalCode", "code": "D014796", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "J Farley Norman", "url": "https://questionsmedicales.fr/author/J%20Farley%20Norman", "affiliation": { "@type": "Organization", "name": "Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu." } }, { "@type": "Person", "name": "Matan Mazor", "url": "https://questionsmedicales.fr/author/Matan%20Mazor", "affiliation": { "@type": "Organization", "name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK." } }, { "@type": "Person", "name": "Rani Moran", "url": "https://questionsmedicales.fr/author/Rani%20Moran", "affiliation": { "@type": "Organization", "name": "Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK." } }, { "@type": "Person", "name": "Stephen M Fleming", "url": "https://questionsmedicales.fr/author/Stephen%20M%20Fleming", "affiliation": { "@type": "Organization", "name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK." } }, { "@type": "Person", "name": "Johan Wagemans", "url": "https://questionsmedicales.fr/author/Johan%20Wagemans", "affiliation": { "@type": "Organization", "name": "Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Validation of 24-hour trough concentration as a proxy for intensive pharmacokinetic measurements for a combined oral contraceptive pill containing desogestrel.", "datePublished": "2023-06-16", "url": "https://questionsmedicales.fr/article/37331464", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.contraception.2023.110093" } }, { "@type": "ScholarlyArticle", "name": "The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.", "datePublished": "2022-10-20", "url": "https://questionsmedicales.fr/article/36265507", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09513590.2022.2134339" } }, { "@type": "ScholarlyArticle", "name": "Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36915205", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13104-023-06304-3" } }, { "@type": "ScholarlyArticle", "name": "The Uncharted Link Between Desogestrel and Hypercalcemia.", "datePublished": "2023-06-17", "url": "https://questionsmedicales.fr/article/37465813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.40577" } }, { "@type": "ScholarlyArticle", "name": "Effects of Pre_Operation Desogestrel Estradiol in Endometrial Preparation at Hysteroscopic Polypectomy.", "datePublished": "2024-04-27", "url": "https://questionsmedicales.fr/article/39234429", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/abr.abr_227_21" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes psychologiques", "item": "https://questionsmedicales.fr/mesh/D011579" }, { "@type": "ListItem", "position": 3, "name": "Processus mentaux", "item": "https://questionsmedicales.fr/mesh/D008606" }, { "@type": "ListItem", "position": 4, "name": "Perception", "item": "https://questionsmedicales.fr/mesh/D010465" }, { "@type": "ListItem", "position": 5, "name": "Perception visuelle", "item": "https://questionsmedicales.fr/mesh/D014796" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Perception visuelle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Perception visuelle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Perception visuelle", "description": "Comment évaluer la perception visuelle ?\nQuels examens pour troubles de la perception ?\nQuels signes indiquent un problème visuel ?\nQuand consulter un spécialiste de la vue ?\nQuelles sont les causes de troubles visuels ?", "url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Desogestrel#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Perception visuelle", "description": "Quels symptômes de troubles de la perception ?\nComment reconnaître une illusion visuelle ?\nQu'est-ce que l'agnosie visuelle ?\nQuels signes d'une fatigue visuelle ?\nComment se manifeste la synesthésie visuelle ?", "url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Desogestrel#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Perception visuelle", "description": "Comment prévenir les troubles de la perception ?\nQuel rôle joue l'alimentation sur la vision ?\nComment réduire la fatigue visuelle ?\nPourquoi éviter le tabac pour la vision ?\nL'exercice physique aide-t-il la vision ?", "url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Desogestrel#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Perception visuelle", "description": "Quels traitements pour troubles de la perception ?\nComment la thérapie visuelle aide-t-elle ?\nLes lunettes corrigent-elles la perception ?\nQuand envisager une chirurgie oculaire ?\nQuels médicaments pour troubles visuels ?", "url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Desogestrel#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Perception visuelle", "description": "Quelles complications des troubles visuels ?\nComment les troubles visuels affectent-ils la vie quotidienne ?\nQuels risques de dépression avec troubles visuels ?\nLes troubles de la perception peuvent-ils s'aggraver ?\nQuelles sont les conséquences d'une agnosie visuelle ?", "url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Desogestrel#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Perception visuelle", "description": "Quels facteurs de risque pour troubles visuels ?\nLe diabète augmente-t-il les risques visuels ?\nComment l'hypertension affecte-t-elle la vision ?\nLe stress influence-t-il la perception visuelle ?\nLes antécédents de traumatismes oculaires sont-ils un risque ?", "url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Desogestrel#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la perception visuelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de vision, comme l'optométrie, évaluent la perception visuelle." } }, { "@type": "Question", "name": "Quels examens pour troubles de la perception ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception." } }, { "@type": "Question", "name": "Quels signes indiquent un problème visuel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème." } }, { "@type": "Question", "name": "Quand consulter un spécialiste de la vue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un ophtalmologiste si vous ressentez des changements soudains de vision." } }, { "@type": "Question", "name": "Quelles sont les causes de troubles visuels ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques." } }, { "@type": "Question", "name": "Quels symptômes de troubles de la perception ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur." } }, { "@type": "Question", "name": "Comment reconnaître une illusion visuelle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs." } }, { "@type": "Question", "name": "Qu'est-ce que l'agnosie visuelle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte." } }, { "@type": "Question", "name": "Quels signes d'une fatigue visuelle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé." } }, { "@type": "Question", "name": "Comment se manifeste la synesthésie visuelle ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons." } }, { "@type": "Question", "name": "Comment prévenir les troubles de la perception ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation sur la vision ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision." } }, { "@type": "Question", "name": "Comment réduire la fatigue visuelle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle." } }, { "@type": "Question", "name": "Pourquoi éviter le tabac pour la vision ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il la vision ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire." } }, { "@type": "Question", "name": "Quels traitements pour troubles de la perception ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie." } }, { "@type": "Question", "name": "Comment la thérapie visuelle aide-t-elle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie visuelle améliore la coordination œil-main et la perception visuelle." } }, { "@type": "Question", "name": "Les lunettes corrigent-elles la perception ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle." } }, { "@type": "Question", "name": "Quand envisager une chirurgie oculaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome." } }, { "@type": "Question", "name": "Quels médicaments pour troubles visuels ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires." } }, { "@type": "Question", "name": "Quelles complications des troubles visuels ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels." } }, { "@type": "Question", "name": "Comment les troubles visuels affectent-ils la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité." } }, { "@type": "Question", "name": "Quels risques de dépression avec troubles visuels ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les troubles visuels augmentent le risque de dépression en raison de l'isolement social." } }, { "@type": "Question", "name": "Les troubles de la perception peuvent-ils s'aggraver ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une agnosie visuelle ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales." } }, { "@type": "Question", "name": "Quels facteurs de risque pour troubles visuels ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques." } }, { "@type": "Question", "name": "Le diabète augmente-t-il les risques visuels ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique." } }, { "@type": "Question", "name": "Comment l'hypertension affecte-t-elle la vision ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels." } }, { "@type": "Question", "name": "Le stress influence-t-il la perception visuelle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter la concentration et la clarté de la perception visuelle." } }, { "@type": "Question", "name": "Les antécédents de traumatismes oculaires sont-ils un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 24/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

J Farley Norman

5 publications dans cette catégorie

Affiliations :
  • Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu.
  • Center for Applied Science in Health and Aging, Western Kentucky University, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu.

Matan Mazor

3 publications dans cette catégorie

Affiliations :
  • Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK.

Rani Moran

3 publications dans cette catégorie

Affiliations :
  • Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.

Stephen M Fleming

3 publications dans cette catégorie

Affiliations :
  • Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK.
  • Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.
  • Department of Experimental Psychology, University College London, London, UK.

Johan Wagemans

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium.
Publications dans "Perception visuelle" :

Rasha Abdel Rahman

2 publications dans cette catégorie

Affiliations :
  • Humboldt-Universität zu Berlin, Berlin, Germany.
Publications dans "Perception visuelle" :

Ziyi Duan

2 publications dans cette catégorie

Publications dans "Perception visuelle" :

Clayton E Curtis

2 publications dans cette catégorie

Publications dans "Perception visuelle" :

Roland W Fleming

2 publications dans cette catégorie

Affiliations :
  • Department of Experimental Psychology, Justus Liebig University Giessen, 35394 Giessen, Germany, and Center for Mind, Brain and Behavior, Universities of Marburg, Giessen and Darmstadt, Germany. Electronic address: roland.w.fleming@psychol.uni-giessen.de.

Patrick Cavanagh

2 publications dans cette catégorie

Affiliations :
  • Department of Psychology, Glendon College; and Center for Vision Research, York University, Toronto, Canada; email: patcav1@yorku.ca.
Publications dans "Perception visuelle" :

Jessica M Dukes

2 publications dans cette catégorie

Affiliations :
  • Department of Psychology, Justus Liebig University Giessen, Giessen, Germany.
Publications dans "Perception visuelle" :

Eline Van Geert

1 publication dans cette catégorie

Affiliations :
  • Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium. eline.vangeert@kuleuven.be.
Publications dans "Perception visuelle" :

Alon Hafri

1 publication dans cette catégorie

Affiliations :
  • Department of Linguistics and Cognitive Science, University of Delaware, Newark, DE, USA. alon@udel.edu; https://pal.lingcogsci.udel.edu/.
Publications dans "Perception visuelle" :

E J Green

1 publication dans cette catégorie

Affiliations :
  • Department of Linguistics and Philosophy, Massachusetts Institute of Technology, Cambridge, MA, USA. ejgr@mit.edu; https://sites.google.com/site/greenedwinj/.
Publications dans "Perception visuelle" :

Chaz Firestone

1 publication dans cette catégorie

Affiliations :
  • Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD, USA. chaz@jhu.edu; https://perception.jhu.edu/.
Publications dans "Perception visuelle" :

Pierre Progin

1 publication dans cette catégorie

Affiliations :
  • Department of Psychiatry, Service of General Psychiatry, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Laboratory of Cognitive Neuroscience, Brain Mind Institute, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
  • Center for Neuroprosthetics, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
Publications dans "Perception visuelle" :

Nathan Faivre

1 publication dans cette catégorie

Affiliations :
  • Department of Psychiatry, Service of General Psychiatry, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Center for Neuroprosthetics, Faculty of Life Sciences, Swiss Federal Institute of Technology, Geneva, Switzerland.
  • CNRS, LPNC UMR 5105, Université Grenoble Alpes, Grenoble, France.
Publications dans "Perception visuelle" :

Anna Brooks

1 publication dans cette catégorie

Affiliations :
  • Lifeline Research Foundation, Lifeline Australia, Deakin ACT, Australia.
  • School of Health and Human Sciences, Southern Cross University, Lismore NSW, Australia.
Publications dans "Perception visuelle" :

Wenwen Chang

1 publication dans cette catégorie

Affiliations :
  • Department of Mechanical Engineering and Automation, Northeastern University, Shenyang, China.
Publications dans "Perception visuelle" :

Manuel Mercier

1 publication dans cette catégorie

Affiliations :
  • Institut de Neurosciences des Systèmes (INS), Inserm (U1106), Aix Marseille University, Marseille, France.
Publications dans "Perception visuelle" :

Sources (28 au total)

Validation of 24-hour trough concentration as a proxy for intensive pharmacokinetic measurements for a combined oral contraceptive pill containing desogestrel.

To confirm that 24-hour steady-state trough measurements (C... We conducted a 12-sample, 24-hour pharmacokinetic study in healthy reproductive-age females taking a COCP containing 0.15-mg desogestrel (DSG) and 30-μg ethinyl estradiol (EE). As DSG is a pro-drug fo... Among 19 participants at steady state, C... Steady-state 24-hour trough concentrations are high-quality proxies for gold standard pharmacokinetics of a DSG-containing COCP.... Use of single-time trough concentration measurements at steady state provides excellent surrogate results for gold standard AUC values for both DSG and EE among COCP users. These findings support that... Clinicaltrials.gov, NCT05002738....

The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.

Dysmenorrhea and mastodynia are the most common gynecologic pain causes in women of all ages and races during their reproductive life. The following study aimed to show the influence of two POP´s in t... A total of 858 women with 6691 drospirenone (DRSP) cycles and 332 women with 2487 desogestrel (DSG) cycles were analyzed. Women included in this study were all child-bearing potentials, at risk of pre... At screening, 168 (19.6%) of the 858 patients using DRSP and 64 (19,3%) of the DSG patients reported that they had suffered from dysmenorrhea within six cycles prior to the first visit before starting... The progestins 4 mg and desogestrel 0,075 mg showed a marked effect in the non-contraceptive aspects of dysmenorrhea and mastodynia so that new possibilities are opened for these two benign gynecologi...

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.

To evaluate if daily oral 75 µg of Desogestrel (DSG) for 3 months prior to the insertion of etonogestrel-releasing contraceptive implant (ENG-IMPLANT) might help reduce its premature discontinuation.... A total of 66 women were randomized in the ENG-IMPLANT group (26) and in the DSG + ENG-IMPLANT group (40), respectively, in the Geneva University Hospitals and Basel University Hospital, from August 1... DSG prior to insertion of the ENG-IMPLANT did not improve its continuation rate neither its satisfaction at 1 year. Trial registration NCT05174195. Retrospectively registered, the 30th December 2021....

Effects of Pre_Operation Desogestrel Estradiol in Endometrial Preparation at Hysteroscopic Polypectomy.

Hysteroscopic surgery is a common gynecologic process in many conditions. Endometrial thinning is the main successful key for this process associated with many preoperative preparations. This study ai... This Randomized clinical trial was done on the patients candidate for polypectomy that were randomly divided into two groups of intervention and control; the first group received DE OCP (oral contrace... There were no significant differences between the parity, polyp size, and BMI (Body Mass Index) in the two groups. The mean duration of surgery, mean endometrial thickness before hysteroscopy, the qua... Pre-operation endometrial thinning by oral contraceptives such as DE could be an effective method and reduce the duration of surgery....

Offering extended use of the contraceptive implant via an implementation science framework: a qualitative study of clinicians' perceived barriers and facilitators.

The etonogestrel contraceptive implant is currently approved by the United States Food and Drug Administration (FDA) for the prevention of pregnancy up to 3 years. However, studies that suggest effica... Using the Consolidated Framework for Implementation Research (CFIR), we conducted semi-structured qualitative interviews. Participants were recruited from a nationwide survey study of reproductive hea... We interviewed 20 clinicians including advance practice clinicians, family medicine physicians, obstetrician/gynecologist and complex family planning sub-specialists. Themes regarding barriers and fac... There is opportunity to expand access to extended use of the contraceptive implant by developing educational materials for clinicians and patients, identifying a champion of extended use, and providin...

An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.

To evaluate if inter-individual variability in serum etonogestrel (ENG) concentrations accounts for variability in mood-related side effects among ENG implant users.... Participants underwent a single-time blood draw for measurement of serum ENG concentrations using a liquid-chromatography mass-spectrometry assay, and completed a questionnaire at enrollment that retr... Among 900 enrolled participants, 34% (306/900) reported mood changes on the baseline questionnaire. Of these, 31 (3.4%) participants also had documented PHQ-9 scores. Serum ENG concentrations (median ... Pharmacokinetic variability does not explain the inter-individual variability in mood-related side effects among ENG implant users.... Mood-related side effects and altered mental health metrics are commonly reported by etonogestrel contraceptive implant users but demonstrate wide inter-individual variability. Individual differences ...

The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study.

Rifampin, a strong CYP3A inducer, is the gold standard for evaluating CYP3A-mediated drug-drug interactions. We aimed to evaluate the pharmacokinetic and pharmacodynamic effects of a short course (2 w... We enrolled healthy females using ENG implants for 12 to 36 months. We measured baseline serum ENG concentrations using a validated liquid chromatography mass-spectrometry assay and baseline E2 and P4... Fifteen participants completed all study procedures. Participants' median age was 28.2 years (range 21.8-34.1), median body-mass index was 25.2 kg/m... With only short exposure to a strong CYP3A inducer, ENG implant users experienced clinically significant decreases in serum ENG concentrations that led to changes in biomarkers indicative of waning su... Even a short, 2-week course of treatment with rifampin places etonogestrel contraceptive implant users at risk for decreased contraceptive efficacy. Clinicians should counsel patients using etonogestr...

Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives.

Oral contraceptives are commonly taken by women and are known to increase the risk of venous thromboembolism (VTE).... The aim of this study was to investigate the association between oral contraceptive use and natural anticoagulants, that is, protein C (PC), protein S (PS), and antithrombin in pregnant women with dee... This case-control study was conducted on 330 pregnant women, that is, cases 165 (who used oral contraceptives) and controls 165 (who did not use oral contraceptives). The levels of PC, PS, and antithr... The study found that women with DVT had significantly lower levels of PC and PS compared with controls ( P < 0.001). However, no significant difference was found in the levels of AT. Among the differe... This study suggests that the use of contraceptives, particularly those containing Desogestrel, Norgestimate, and Gestodene, may be associated with a higher risk of thrombosis because of the associated...

The effect of Ding-kun-dan comparing with Marvelon on primary dysmenorrhea: A prospective, double-blind, multicenter, randomized controlled trial.

Ding-kun-dan (DKD), as one of well-known traditional Chinese medicine (TCM), is considered as an effective prescription to regulate menstruation, benefit Qi and nourish the blood. Previous studies had... To compare the effect of Ding-kun-dan (DKD) with Marvelon on relief of symptoms and change of serum pain-related factors in patients with primary dysmenorrhea.... 136 patients with primary dysmenorrhea were randomly assigned to the DKD group (n = 73, take one tablet per day from 5th day of the menstrual cycle for 10 days every 28 days) and the Marvelon group (n... Both DKD and Marvelon could effectively relief pain and other associated symptoms at each visit (Baseline, 4... Ding-kun-dan is another available, effective and safe method for patients with primary dysmenorrhea to choose, especially for those who are suffered from mild pain and/or contraindicated to hormonal a...